Sara Bokelund-Singh

机构：AstraZeneca (Sweden), Stanford University

发表论文 6 篇 · 总被引 51 次 · h-index 3

代表论文

• Risk for Major Bleeding in Patients Receiving Ticagrelor Compared With Aspirin After Transient Ischemic Attack or Acute Ischemic Stroke in the SOCRATES Study (Acute Stroke or Transient Ischemic Attack Treated With Aspirin or Ticagrelor and Patient Outcomes) (2017 · Circulation · 被引 34)
• Pharmacokinetic Profiles of Ticagrelor Orodispersible Tablets in Healthy Western and Japanese Subjects (2017 · Clinical Drug Investigation · 被引 12)
• Acid Control Cannot Be Improved with a Modified-Release Formulation of a Proton Pump Inhibitor Compared with Twice-Daily Dosing of the Conventional Formulation (2010 · Digestive Diseases and Sciences · 被引 5)
• P3695Pharmacokinetic profiles of orodispersible ticagrelor tablets in healthy Western and Japanese subjects (2017 · European Heart Journal)
• Can Acid Control Be Improved with a Modified-Release Formulation of a Proton Pump Inhibitor? (2008 · The American Journal of Gastroenterology)
• Dose and Timing Effects of Esomeprazole Administration on 24-H Intragastric pH Control (2008 · The American Journal of Gastroenterology)